Financial Results
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) Reports Year Ended 31/12/2025 Standalone Results
Published at 31 March 2026 at 11:43Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-RamedaRelated stock:Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda stockAll Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda disclosures
Disclosure summary
Company Name : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Standalone Period : From 01/01/2025 To 31/12/2025
Net Profit : 312,714,741
F/S Standalone Period : From 01/01/2024 To 31/12/2024
Net Comparative Profit : 373,237,135
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The BoD Report (3,562 KB)
ISIN Code : EGS381B1C015
Currency : EGP
F/S Standalone Period : From 01/01/2025 To 31/12/2025
Net Profit : 312,714,741
F/S Standalone Period : From 01/01/2024 To 31/12/2024
Net Comparative Profit : 373,237,135
Audit Status : Audited
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The BoD Report (3,562 KB)